This person is not registered. Is this you?

Profile Details
Y Yang

Penn State university

Institute for Physiological Chemistry
Institute of Oncology

Autonomous University of Madrid
Department of Biological Sciences

College of Pharmacy, Wuhan University, China
Department of Biomedical Engineering

Sichuan University, Chengdu, China

UK Dept of Health

School of Biomedical Sciences, University of Newcastle

Ludwig Institute for Cancer Research, Uppsala University
Department of Ecology and Genetics

Peking University Research Center on Aging, Peking University Health Science Center,

Institute of Clinical Medicine, University of Tsukuba

Capital Medical University, Beijing Tongren Hospital
Department of Pathology

Tongji Hospital of Tongji University
Department of Surgery

Jilin University

University of North Carolina School of Medicine

Ningbo University

University of Macau

Beijing Normal University
Department of Biochemistry and Molecular Biology

Tongji University School of Medicine-Shanghai Pulmonary Hospital

Sun Yat-sen University Cancer Center,
Department of Endoscopy

Guangdong Provincial Hospital of Chinese Medicine China

Beijing University of Chinese Medicine

Medical College of Soochow University
Department of Hepatobiliary Pancreatic Surgery

Fudan University Shanghai Cancer Center
1Department of Medical Oncology

Nantong University

Cancer Hospital of Tianjin Medical University
Department of Anesthesia

Xiamen University
2Department of Urology

Nanjing University of Aeronautics and Astronautics
Department of Biomedical Engineering

University of Chinese Academy of Sciences

Physikdepartment der Technischen Universität München
Department of Radiology


Philadelphia, PA
My Blogs:
My Twitter Hashtags:
[1]Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, #38 Xueyuan Road, Beijing 100191, China.
Cancer Biology, Cancer Immunotherapy
Presented at Events Covering:
, Antibodies, Bioenergetics, Biology, Biotechnology, Cancer Biology, Cell Biology, Cytokine, Drug Design, Genomics, Microscopy, Molecular Biology, Proteomics, Stem Cells
Areas of Interest:
General Comments:
BSN Rank: 4872 / 2941 (What's this?)
Accomplish Score: 37
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 31793
We'll Post Your CV for Free!
Speaking/Presenting-Abstract/Poster at Mtg: 1 (13 / 0)
Honors and Awards: 0 (0 / 0)
Clinical Trial Activity: 0 (0 / 0)
Grant Support: 0 (0 / 0)
Patents Pending: 0 (0 / 0)
Journal - Editor/Reviewer: 0 (0 / 0)
Peer Reviewed Papers, Books, Chapters: 4 (24 / 0)
  • Lung cancer still remains the leading cause of cancer-related death worldwide. ()
  • Background: The use of PCI in early operable patients with small cell lung cancer (SCLC) is still controversial. ()
  • Gefitinib, an EGFR tyrosine kinase inhibitor, is used to treat non-small cell lung cancer (NSCLC) patients with activating EGFR mutations. ()
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
Membership in Professional Societies: 0 (0 / 0)
White Papers: 0 (0 / 0)
Registered on BiotechScienceNews: 0

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.